KKR invests in Pittsburgh company
10.20.15
Cohera Medical will use the first tranche of a $50M equity financing from international investment firm KKR and private investors to launch U.S. commercial seas of TissueGlu and toward advancing clinical trials for Sylys. The investment firm KKR has invested in Cohera Medical.